Skip to main content
. 2002 May;46(5):1481–1491. doi: 10.1128/AAC.46.5.1481-1491.2002

TABLE 1.

Demographic and clinical features at the time of presentation of children with bacteremia due to either ESBL-producing or ESBL-nonproducing E. coli or K. pneumoniae

Characteristic ESBL group (n = 49) Non-ESBL group (n = 93) P valuea
Sex (no. of males: no. of females) 27:22 54:39 0.79
Mean ± standard deviation age (yr) 4.58 ± 5.02 7.17 ± 5.97 0.01
Status or underlying disease (no. of episodes)
    Hematological malignancy 22 44 0.77
    Solid tumor 9 10 0.21
    Steroid user 1 5 0.66
    Preterm 6 6 0.24
    Neonate 3 4 0.45
    Othersb 8 18 0.66
    Nonec 0 6 0.09
Focus of infection (no. [%] of episodes) 13 (27) 39 (42) 0.07
    Pneumonia 6 7 0.35
    Peritonitis 1 5 0.66
    Urinary tract infection 3 8 0.75
    Abscess 1 4 0.72
    Cellulitis 0 5 0.72
    Ascending cholangitis 2 6 0.72
    Meningitis/acute otitis media/septic knee/typhlitis 0 1/1/1/1
Presenting condition at sepsis onset or presentationd
    Shock 6/42 8/87 0.384
    Hypothermia 2/42 2/87 0.596
    Renal insufficiency 1/42 5/86 0.663
    Hepatic dysfunction 9/41 25/86 0.397
    Neurological dysfunction 1/41 1/87 0.540
    Respiratory difficulty in case of pneumonia 0/6 0/7
a

Association was evaluated by Pearson's χ2 test or Fisher's exact test for all parameters except age, which was compared by the Student t test.

b

Others include biliary atresia (n = 8 episodes), chronic renal diseases (n = 3); chronic encephalopathy (n = 3); congenital neuromuscular diseases (n = 2); bronchopulmonary dysplasia (n = 2); chronic hepatitis (n = 2); failure to thrive (n = 2), and one episode each of congenital heart disease, Kasabach-Meritt syndrome, intestinal pseudo-obstruction with central venous catheter, and toxic shock syndrome.

c

These six patients were associated with urinary tract infections (4 cases) or acute appendicitis (2 cases).

d

The values represent the number of episodes with the indicated condition/total number of patients evaluated.

HHS Vulnerability Disclosure